For instance, an ultrashort peptide-based hydrogel derived from the C-region of insulin-like growth factor 1 (IGF-1) formed supramolecular nanofibers and was used for the treatment of GC-induced sarcopenia, with a biological activity surpassing that of IGF-1 [30]. Here, IGF1 is linked to sarcopenia.